Back to top

Image: Bigstock

Is Aperam (APEMY) a Great Value Stock Right Now?

Read MoreHide Full Article

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.

Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.

In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.

One stock to keep an eye on is Aperam (APEMY - Free Report) . APEMY is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. The stock is trading with P/E ratio of 12.75 right now. For comparison, its industry sports an average P/E of 20.24. Over the last 12 months, APEMY's Forward P/E has been as high as 15.71 and as low as 6.80, with a median of 9.51.

We should also highlight that APEMY has a P/B ratio of 0.94. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. This stock's P/B looks attractive against its industry's average P/B of 1.13. Over the past 12 months, APEMY's P/B has been as high as 0.97 and as low as 0.62, with a median of 0.81.

These figures are just a handful of the metrics value investors tend to look at, but they help show that Aperam is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, APEMY feels like a great value stock at the moment.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Aperam (APEMY) - free report >>

Published in